Overview
Ruud Delwel practices in Rotterdam, Netherlands. Delwel is rated as a Distinguished expert by MediFind in the treatment of Acute Myeloid Leukemia (AML). Their top areas of expertise are Acute Myeloid Leukemia (AML), Leukemia, Chromosome 7p Deletion, and Myelodysplastic Syndrome (MDS).
Their clinical research consists of co-authoring 87 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 58 articles in the study of Acute Myeloid Leukemia (AML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Acute Myeloid Leukemia (AML)Delwel isDistinguished. Learn about Acute Myeloid Leukemia (AML).
- LeukemiaDelwel isDistinguished. Learn about Leukemia.
- Advanced
- Chromosome 7p DeletionDelwel isAdvanced. Learn about Chromosome 7p Deletion.
- Experienced
- Myelodysplastic Syndrome (MDS)Delwel isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- Paroxysmal Cold HemoglobinuriaDelwel isExperienced. Learn about Paroxysmal Cold Hemoglobinuria.
- Paroxysmal Nocturnal Hemoglobinuria (PNH)